Citigroup
SPPI

Citigroup’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Citigroup’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,064
Closed -$1K – 6071
2022
Q3 		$1K Sell
2,064
-2,096
-50% -$2.06K ﹤0.01% 5737
2022
Q2 		$3K Sell
4,160
-10,617
-72% -$9.36K ﹤0.01% 5828
2022
Q1 		$19K Sell
14,777
-115,582
-89% -$106K ﹤0.01% 5192
2021
Q4 		$166K Sell
130,359
-397,075
-75% -$710K ﹤0.01% 4447
2021
Q3 		$1.15M Sell
527,434
-121,556
-19% -$332K ﹤0.01% 2984
2021
Q2 		$2.43M Sell
648,990
-82,639
-11% -$287K ﹤0.01% 2517
2021
Q1 		$2.38M Buy
731,629
+677,577
+1,254% +$2.43M ﹤0.01% 2385
2020
Q4 		$184K Buy
54,052
+37,707
+231% +$155K ﹤0.01% 5056
2020
Q3 		$66K Sell
16,345
-94,120
-85% -$358K ﹤0.01% 5412
2020
Q2 		$373K Buy
110,465
+32,301
+41% +$94.1K ﹤0.01% 4525
2020
Q1 		$183K Buy
78,164
+16,689
+27% +$45.7K ﹤0.01% 4808
2019
Q4 		$224K Sell
61,475
-163,996
-73% -$1.33M ﹤0.01% 5092
2019
Q3 		$1.87M Buy
225,471
+100,932
+81% +$816K ﹤0.01% 2949
2019
Q2 		$1.07M Buy
124,539
+63,871
+105% +$571K ﹤0.01% 3536
2019
Q1 		$648K Sell
60,668
-434,749
-88% -$4.66M ﹤0.01% 3902
2018
Q4 		$4.33M Buy
495,417
+449,504
+979% +$5.73M ﹤0.01% 1940
2018
Q3 		$771K Sell
45,913
-163,390
-78% -$3.54M ﹤0.01% 3780
2018
Q2 		$4.39M Buy
209,303
+94,428
+82% +$1.75M ﹤0.01% 1959
2018
Q1 		$1.85M Sell
114,875
-51,217
-31% -$1.01M ﹤0.01% 2666
2017
Q4 		$3.15M Buy
166,092
+58,725
+55% +$1.06M ﹤0.01% 2252
2017
Q3 		$1.51M Sell
107,367
-25,254
-19% -$228K ﹤0.01% 2947
2017
Q2 		$988K Buy
132,621
+41,487
+46% +$271K ﹤0.01% 3331
2017
Q1 		$592K Sell
91,134
-26,083
-22% -$146K ﹤0.01% 3723
2016
Q4 		$520K Buy
117,217
+44,575
+61% +$187K ﹤0.01% 4341
2016
Q3 		$340K Buy
72,642
+42,176
+138% +$250K ﹤0.01% 4246
2016
Q2 		$200K Sell
30,466
-22,338
-42% -$158K ﹤0.01% 4499
2016
Q1 		$336K Buy
52,804
+43,015
+439% +$221K ﹤0.01% 4575
2015
Q4 		$59K Sell
9,789
-40,009
-80% -$229K ﹤0.01% 5802
2015
Q3 		$298K Buy
49,798
+43,530
+694% +$302K ﹤0.01% 4196
2015
Q2 		$43K Buy
6,268
+119
+2% +$756 ﹤0.01% 5634
2015
Q1 		$37K Sell
6,149
-12,342
-67% -$82.1K ﹤0.01% 5719
2014
Q4 		$128K Buy
18,491
+11,398
+161% +$83.8K ﹤0.01% 5045
2014
Q3 		$58K Sell
7,093
-3,669
-34% -$28.7K ﹤0.01% 5200
2014
Q2 		$87K Sell
10,762
-11,630
-52% -$88.2K ﹤0.01% 4768
2014
Q1 		$176K Sell
22,392
-32,917
-60% -$279K ﹤0.01% 4461
2013
Q4 		$489K Buy
55,309
+25,749
+87% +$230K ﹤0.01% 3810
2013
Q3 		$248K Sell
29,560
-4,994
-14% -$40.4K ﹤0.01% 3979
2013
Q2 		$258K Buy
+34,554
New +$265K ﹤0.01% 4066

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Citigroup's SPPI Position: Q4 2022 in Review

Citigroup sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 2,064 shares — an estimated $1K sold.

Citigroup first reported a position in SPPI in Q2 2013 and held it in 38 quarters. The position peaked at $4.39M in Q2 2018. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • Citigroup reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 2,064 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $1K.
  • Citigroup first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 38 quarters.
  • Citigroup's Spectrum Pharmaceuticals Inc position peaked at $4.39M in Q2 2018.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.